Massa, A.; Vita, F.; Peraldo-Neia, C.; Varamo, C.; Basiricò, M.; Raggi, C.; Bernabei, P.; Erriquez, J.; Leone, F.; Aglietta, M.;
et al. Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma. Cancers 2025, 17, 132.
https://doi.org/10.3390/cancers17010132
AMA Style
Massa A, Vita F, Peraldo-Neia C, Varamo C, Basiricò M, Raggi C, Bernabei P, Erriquez J, Leone F, Aglietta M,
et al. Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma. Cancers. 2025; 17(1):132.
https://doi.org/10.3390/cancers17010132
Chicago/Turabian Style
Massa, Annamaria, Francesca Vita, Caterina Peraldo-Neia, Chiara Varamo, Marco Basiricò, Chiara Raggi, Paola Bernabei, Jessica Erriquez, Francesco Leone, Massimo Aglietta,
and et al. 2025. "Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma" Cancers 17, no. 1: 132.
https://doi.org/10.3390/cancers17010132
APA Style
Massa, A., Vita, F., Peraldo-Neia, C., Varamo, C., Basiricò, M., Raggi, C., Bernabei, P., Erriquez, J., Leone, F., Aglietta, M., Cavalloni, G., & Marchiò, S.
(2025). Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma. Cancers, 17(1), 132.
https://doi.org/10.3390/cancers17010132
